Taiyo Corporation (Head office: Minato-ku, Tokyo; CEO: Mariko Nakabe) has been selected for the “2025 WHO prequalification and recommendation acquisition and WHO recommended equipment listing promotion project for developing countries”.

WHO (World Health Organization) prequalification and recommendation are intended to promote the efforts of Japanese companies to be listed in the WHO compendium of innovative health technologies for low-resource settings, contributing to improving medical standards in developing countries while promoting the international expansion of high-quality Japanese pharmaceuticals and medical equipment.

With your support, we will strive to contribute to clinical settings and society through the development of mobile lighting that can be used in a variety of surgical environments.

■Contact information
For inquiries regarding this matter, please contact us at:
Taiyo Corporation, Medical Division
TEL: +81(0)3-5440-6273(Weekdays 10:00-17:00)
OPELAIII Cx HP: https://www.opela3.com/en/